Table 2: Therapy received at stage of disease.
|
|
Caucasian |
Hispanic |
African American |
Asian |
Other |
|
|
|
|
|
|
|
|
|
|
Stage 1 to 3 |
|
|
|
|
|
|
|
n |
1052 |
188 |
142 |
230 |
9 |
|
|
No Treatment |
30.70% |
25.50% |
27.50% |
26.50% |
33.30% |
|
|
Surgery |
6.90% |
10.60% |
9.90% |
5.20% |
|
|
|
Chemo |
24.00% |
21.80% |
23.90% |
27.00% |
11.10% |
|
|
Surgery + Chemo |
23.10% |
22.90% |
21.80% |
27.40% |
33.30% |
|
|
Radiation |
1.50% |
|
0.70% |
1.70% |
|
|
|
Radiation + Chemo |
6.70% |
9.00% |
4.90% |
5.70% |
|
|
|
Surgery + Chemo + XRT |
7.00% |
10.10% |
11.30% |
6.50% |
22.20% |
P = 0.849 |
|
OS survival (months) |
20.5 |
25.1 |
24.2 |
24.2 |
16.4 |
P = 0.233 |
|
|
|
|
|
|
|
|
|
Stage 4 |
|
|
|
|
|
|
|
n |
1306 |
229 |
178 |
278 |
8 |
|
|
No Treatment |
53.90% |
48.50% |
48.30% |
50.70% |
50.00% |
|
|
OS Survival (months) |
6.1 |
7.9 |
6.6 |
6.9 |
4.5 |
P = 0.115 |
|
OS with Palliative Treatment |
10.7 |
12.3 |
10.4 |
11.6 |
7.3 |
P = 0.503 |
|
Treatment Age 75 or Greater |
7.9 |
8.8 |
7 |
8.5 |
5 |
P = 0.922 |
|
Treatment Age < 75 |
11.3 |
13.1 |
11.4 |
12.5 |
8 |
P = 0.548 |